Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Common Equity (2016 - 2025)

Historic Common Equity for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $2.0 billion.

  • Select Medical Holdings' Common Equity fell 1140.02% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year decrease of 1140.02%. This contributed to the annual value of $2.0 billion for FY2024, which is 2837.79% up from last year.
  • Per Select Medical Holdings' latest filing, its Common Equity stood at $2.0 billion for Q3 2025, which was down 1140.02% from $2.0 billion recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' Common Equity peaked at $2.3 billion during Q3 2024, and registered a low of $1.3 billion during Q2 2022.
  • Moreover, its 5-year median value for Common Equity was $1.5 billion (2023), whereas its average is $1.6 billion.
  • Per our database at Business Quant, Select Medical Holdings' Common Equity soared by 4900.91% in 2024 and then tumbled by 1140.02% in 2025.
  • Over the past 5 years, Select Medical Holdings' Common Equity (Quarter) stood at $1.3 billion in 2021, then grew by 2.31% to $1.4 billion in 2022, then rose by 14.09% to $1.5 billion in 2023, then rose by 28.38% to $2.0 billion in 2024, then grew by 1.22% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q3 2025, $2.0 billion for Q2 2025, and $2.0 billion during Q1 2025.